Pulse Biosciences (NASDAQ:PLSE - Get Free Report) announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.25) EPS for the quarter, Zacks reports.
Pulse Biosciences Stock Performance
Shares of NASDAQ:PLSE traded down $0.04 on Thursday, reaching $16.26. 61,769 shares of the company's stock were exchanged, compared to its average volume of 197,337. Pulse Biosciences has a twelve month low of $6.66 and a twelve month high of $25.00. The company has a fifty day moving average of $16.59 and a 200-day moving average of $17.99.
Analysts Set New Price Targets
Separately, StockNews.com raised Pulse Biosciences to a "sell" rating in a research note on Monday, March 31st.
Check Out Our Latest Stock Analysis on Pulse Biosciences
Pulse Biosciences Company Profile
(
Get Free Report)
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Stories
Before you consider Pulse Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pulse Biosciences wasn't on the list.
While Pulse Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
